SUPRAME Trademark

Trademark Overview

On Wednesday, March 26, 2025, a trademark application was filed for SUPRAME with the United States Patent and Trademark Office. The USPTO has given the SUPRAME trademark a serial number of 99104160. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, March 26, 2025. This trademark is owned by Immatics Biotechnologies GmbH. The SUPRAME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting of medical, scientific and clinical studies in the field of engineered T-cell receptor-based immunotherapy against solid cancer; conducting clinical trials and analyses in the field of engineered T-cell receptor-based immunotherapy against solid cancer, and providing corresponding information
suprame

General Information

Serial Number99104160
Word MarkSUPRAME
Filing DateWednesday, March 26, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, March 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesConducting of medical, scientific and clinical studies in the field of engineered T-cell receptor-based immunotherapy against solid cancer; conducting clinical trials and analyses in the field of engineered T-cell receptor-based immunotherapy against solid cancer, and providing corresponding information

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 26, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmatics Biotechnologies GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTübingen 72076
DE

Trademark Events

Event DateEvent Description
Wednesday, March 26, 2025NEW APPLICATION ENTERED
Wednesday, March 26, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

suprame conducting receptor immunotherapy against cancer solid cell based engineered clinical